Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1472474 | 0.82 | CHRNB2 (0.41) | CHRNB2CHRNA4SIGMAR1TSHRMEN1 | |
| SCHEMBL3210075 | 0.72 | NPC1 (0.50) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| SCHEMBL15281415 | 0.71 | CHRNB2 (0.38) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| Benzene SCHEMBL28160719 | 0.71 | NPC1 (0.49) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| SCHEMBL586754 | 0.71 | NPC1 (0.49) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| SCHEMBL21125962 | 0.68 | CHRNB2 (0.46) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| SCHEMBL2402920 | 0.68 | ALDH1A1 (0.46) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| SCHEMBL14262957 | 0.68 | CHRNB2 (0.38) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| SCHEMBL12751442 | 0.68 | CHRNB2 (0.38) | CHRNB2CHRNA4TSHRMEN1KMT2A | |
| SCHEMBL12751297 | 0.68 | CHRNB2 (0.38) | CHRNB2CHRNA4TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130096305-A1 | DEUTERATED HIV ATTACHMENT INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096305-A1 | DEUTERATED HIV ATTACHMENT INHIBITORS | VCAM1, CD4, ICAM1 | CHRNB2 4766/4885CHRNA4 3835/4885SIGMAR1 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.